Defects in BRCA1 and BRCA2 are well known genetic risks [3, 4], and mutations in many other genes are also associated with ovarian cancer, such as MSH2, MSH6, and TP53 [5–9], but in many cases the involved genetic factors remain unknown. This evidence concerns the gene BRCA1 and ovarian cancer.